H. Fujita

发表

[Anticancer drugs].

H. Fujita, 1995, Nihon rinsho. Japanese journal of clinical medicine.

A safety and survival analysis of neoadjuvant bevacizumab with standard chemoradiation in a phase I/II study compared with standard chemoradiation in locally advanced rectal cancer.

Jeffrey W. Clark, R. Jain, R. Bentley, 2010, The oncologist.

O6-Alkylguanine-DNA alkyltransferase activity of human malignant glioma and its clinical implications

K. Kurisu, K. Ishizaki, Yuji Saito, 2005, Journal of Neuro-Oncology.

Effect of PSK, a protein-bound polysaccharide from Coriolus versicolor, on drug-metabolizing enzymes in sarcoma-180 bearing and normal mice.

Y. Kawai, S. Muto, H. Fujita, 1988, International journal of immunopharmacology.

Comparison of the effects of acarbose and voglibose on Plasma glucose, endogenous insulin sparing, and gastrointestinal adverse events in obese subjects : A randomized, placebo-controlled, double-blind, three-way crossover study

H. Fujita, S. Kageyama, N. Nakamichi, 2000 .

[Clinical result of thermochemoradiotherapy for advanced head and neck cancer].

M. Nagata, H. Hoshina, R. Takagi, 2001, Gan to kagaku ryoho. Cancer & chemotherapy.

Branched-chain amino acids metabolic support in surgical patients: a randomized, controlled trial in patients with subtotal or total gastrectomy in 16 Japanese institutions.

H. Fujita, A. Okada, T. Itakura, 1988, JPEN. Journal of parenteral and enteral nutrition.

[Pharmacokinetics of SK & F 104864 in experimental animals. I. Plasma level].

H. Fujita, M. Okamoto, A. Takao, 1995, Gan to kagaku ryoho. Cancer & chemotherapy.

[A case of curatively resected AFP producing gastric cancer that responded remarkably to 1 course of TS-1 and showed complete loss of multiple liver metastatic tumors].

H. Fujita, Junji Imamura, Y. Endo, 2005, Gan to kagaku ryoho. Cancer & chemotherapy.

Pharmacokinetics of doxorubicin, (2"R)-4'-O-tetrahydropyranyl-adriamycin and aclarubicin.

H. Fujita, H. Iguchi, H. Tone, 1986, The Japanese journal of antibiotics.

A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer.

I. Hyodo, K. Muro, A. Ohtsu, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[Pharmacokinetics of paclitaxel in experimental animals. Part 2. Tissue distribution].

H. Fujita, M. Okamoto, A. Takao, 1994, Gan to kagaku ryoho. Cancer & chemotherapy.

[Phase I study of S-1. S-1 Study Group].

K. Sugimachi, R. Kanamaru, T. Taguchi, 1997, Gan to kagaku ryoho. Cancer & chemotherapy.

[Pharmacokinetics of fluoropyrimidines].

H. Fujita, 1984, Gan to kagaku ryoho. Cancer & chemotherapy.

[Pharmacokinetics of mitomycin C and its derivative (KW-2083)].

H. Fujita, 1982, Gan to kagaku ryoho. Cancer & chemotherapy.

Competitive Binding Radioassay for the Determination of 5‐Fluorodeoxyuridine and 5‐Fluorodeoxyuridine‐5′‐monophosphate Levels in Plasma and Tumor Tissue

H. Fujita, Seiji Miyata, H. Mikami, 1991, Japanese journal of cancer research : Gann.

[Pharmacokinetics and antitumor activity of MX2, a new morpholino anthracycline in brain tumor intracerebral transplanted in rats].

K. Sugiyama, K. Kurisu, H. Fujita, 1993, Gan to kagaku ryoho. Cancer & chemotherapy.

In Vivo Distribution and Activation of 1-Hexylcarbamoyl-5-fluorouracil (HCFU)

H. Fujita, K. Ogawa, 1981 .